Capsule’s Ventilated Patient Surveillance Workstation Helping to Meet Hospital Care Demands for Critical COVID-19 Patients

ANDOVER, Mass., May 21, 2020 /PRNewswire/ — As hospitals confront the COVID-19 pandemic, caregivers need tools to help them manage a large and dispersed population of ventilated patients safely and effectively. To that end, Capsule Technologies offered the Ventilated Patient Surveillance (VPS) workstation providing present users of the company’s Medical Device Information Platform centralized remote observation of patients’ ventilator data and clinically actionable emergent events.

Assisting frontline providers in identifying patients in severe respiratory distress increases the likelihood of survival and reduces the burden on already-stressed care providers. The VPS workstation extends the reach of intensive care unit (ICU) staff over the full range of critical care patients, whether these patients receive care in the traditional ICU, other dedicated areas of the hospital, or non-traditional care settings.

Viewing real-time and trended clinical respiratory measurements and annunciated clinically actionable emergent events from a VPS workstation in a centralized, remote location allows staff to manage patients closely, without having to be physically close. Reducing bedside visits for non-actionable events limits the caregivers’ exposure to infection and reduces their consumption of personal protective equipment (PPE), which saves time, money and the equipment itself, another valuable resource in short supply. Care providers have greater availability for actual clinically actionable events, leading to shortened response times, which can improve patient safety and outcomes.  

Ventilated patient surveillance leverages the ventilator connectivity of the Capsule Medical Device Information Platform, which is already being used in over 2,000 hospitals in the U.S. The VPS workstation is a tailored configuration of the company’s Capsule Surveillance solution, which integrates a wide range of patient monitoring and therapy devices, in addition to ventilators. Capsule is offering the VPS workstation to its customers in the U.S., where Capsule Surveillance has FDA clearance.

Supporting Frontline Clinicians
The Capsule VPS workstation is already in use by several leading healthcare organizations, including the University of Miami Health System. “Implementation went quickly and smoothly, which was helpful during the rush of coronavirus cases,” said Mary Stein-Ferrer, director of clinical informatics for University of Miami Health System. “We have used ventilated patient surveillance to identify clinically actionable emergent events. Viewing and assessing comprehensive ventilation data on the workstation before entering a patient room reduces the amount of time that our nurses and respiratory therapists spend in that potentially infectious environment.”

Other hospitals and health systems that have successfully implemented the Ventilated Patient Surveillance workstation include Massachusetts General Hospital, Nebraska Medicine, Virginia Hospital Center, Middlesex Health and Capsule’s initial launch partner for the VPS workstation, Yale New Haven Health.

“For our existing clients, adding ventilated patient surveillance is a simple, yet impactful, way to extend the utility of their Capsule installations,” said Hemant Goel, chief executive officer of Capsule Technologies. “Technology is a key enabler, and we are directing all resources to support our clients’ urgent needs to reduce risks, increase efficiencies and extend the reach and availability of resources. Our Ventilated Patient Surveillance workstation offers remote, continuous visibility on critical, respiratory-compromised COVID-19 patients while supporting clinical decisions and helping staff limit their exposure.”

Designed for Rapid and Remote Deployment in Hospitals 
Recognizing that the pandemic has made travel and going on-site at hospitals difficult, Capsule engineers designed the VPS workstation so that the entire solution can be implemented remotely in a matter of hours, with support from the hospital’s IT staff.

For more information, visit capsuletech.com, or contact Capsule Technologies at 1-800-260-9531 or support@capsuletech.com.

About Capsule Technologies 
Capsule Technologies is a leading global provider of medical data technologies for hospitals and healthcare organizations. Our Medical Device Information Platform — comprised of device integration, vital signs monitoring, and clinical surveillance solutions — captures streaming clinical data from connected systems and transforms it into context-rich information for clinical documentation, alarm management, patient surveillance, decision support, predictive analytics, clinical research and more. End-to-end data management and connectivity supports better collaboration and communication between clinicians and departments. More than 2,800 global clients leverage our platform to improve patient safety, simplify workflows and raise overall satisfaction throughout the hospital and across care settings. Learn more at www.capsuletech.com.

Media contact:
Philip Anast
Amendola Communications for Capsule Technologies, Inc.
(312) 576-6990
panast@acmarketingpr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/capsules-ventilated-patient-surveillance-workstation-helping-to-meet-hospital-care-demands-for-critical-covid-19-patients-301063138.html

SOURCE Capsule Technologies

Staff

Recent Posts

Nano Labs Announces Receipt of Deficiency Letters from Nasdaq

HANGZHOU, China, July 12, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or…

4 hours ago

Inhance Technologies’ Statement in Response to EPA’s Section 6 Approach on Fluorination of Plastic Containers

HOUSTON, July 12, 2024 /PRNewswire/ -- Inhance Technologies welcomes the opportunity to engage with the…

10 hours ago

Global High-Throughput Screening (HTS) Market to Reach USD 50.2 Billion by 2029: Opportunities, Challenges, and Growth Drivers | MarketsandMarkets™

CHICAGO, July 12, 2024 /PRNewswire/ -- The global high-throughput screening market is poised for substantial growth,…

10 hours ago

PPG Biosensors Market to be dominated by Smartwatches Segment to reach USD 1001.73 Mn by 2030- Says Stellar Market Research

PUNE, India, July 12, 2024 /PRNewswire/ -- Stellar Market Research, a leading Healthcare business research…

10 hours ago

ImmuneAGE Bio launches to rejuvenate the immune system targeting bone marrow stem cells

SAN JUAN, Puerto Rico and LAUSANNE, Switzerland, July 12, 2024 /PRNewswire/ -- ImmuneAGE Bio raised…

10 hours ago